(Q43777338)

26 November 2017

title

Chelating activity of advanced glycation end-product inhibitors (English)

1 reference

26 November 2017

Price DL

1

1 reference

26 November 2017

Rhett PM

series ordinal

2

1 reference

26 November 2017

Thorpe SR

series ordinal

3

1 reference

26 November 2017

Baynes JW

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

24 October 2001

1 reference

Journal of Biological Chemistry

26 November 2017

published in

1 reference

26 November 2017

volume

276

1 reference

26 November 2017

issue

52

1 reference

26 November 2017

page(s)

48967-48972

1 reference

Role of the Maillard reaction in diabetes mellitus and diseases of aging

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Biological effects of aminoguanidine: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Human type 2 diabetes: morphological evidence for abnormal beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Protein glycation and oxidative stress in diabetes mellitus and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Novel inhibitors of advanced glycation endproducts (part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Novel inhibitors of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Glycochelates and the etiology of diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Effects of an extracellular metal chelator on neurovascular function in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Carnosine: its properties, functions and potential therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

Glucose Modification of Human Serum Albumin: A Structural Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108196200

21 January 2018

Identifiers

DOI

10.1074/JBC.M108196200

1 reference

26 November 2017

1 reference